Record #35993
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Journal
Publisher
Original paper date
Jul 5, 2021
Original DOI
Country
Institution
Open access
No
Article type
Notes from Retraction Watch
see: https://www.sciencedirect.com/science/article/abs/pii/S1470204522000663;
Citation lifecycle
How this paper is being cited
Pre-retraction
11
Same day
0
Post-retraction
53
% post-retraction
82.8%
~16.3 citations/yr before retraction · ~11.7 citations/yr after
— citing papers
Who is still citing this work
Loading…